[go: up one dir, main page]

WO2000008045A3 - Nouvelles molecules de la famille de proteines apparentees a tango-93 et leurs utilisations - Google Patents

Nouvelles molecules de la famille de proteines apparentees a tango-93 et leurs utilisations Download PDF

Info

Publication number
WO2000008045A3
WO2000008045A3 PCT/US1999/017886 US9917886W WO0008045A3 WO 2000008045 A3 WO2000008045 A3 WO 2000008045A3 US 9917886 W US9917886 W US 9917886W WO 0008045 A3 WO0008045 A3 WO 0008045A3
Authority
WO
WIPO (PCT)
Prior art keywords
tango
nucleic acid
proteins
related protein
protein family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/017886
Other languages
English (en)
Other versions
WO2000008045A2 (fr
Inventor
Yang Pan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Priority to AU57722/99A priority Critical patent/AU5772299A/en
Publication of WO2000008045A2 publication Critical patent/WO2000008045A2/fr
Publication of WO2000008045A3 publication Critical patent/WO2000008045A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des polypeptides, des protéines et des molécules d'acide nucléique de type TANGO-93. A côté de protéines TANGO-93 complètes isolées, l'invention porte sur des protéines de fusion TANGO-93 isolées, des peptides antigèniques et des anticorps anti-TANGO-93. Cette invention concerne également des molécules d'acides nucléique TANGO-93, des vecteurs d'expression recombinants renfermant une molécule d'acide nucléique selon l'invention des cellules hôtes dans lesquelles ont été introduits les vecteurs d'expression et des animaux transgéniques non humains dans lesquels un gène TANGO-93 a été introduit, puis inactivé. Sont également décrites des méthodes de diagnostic, de criblage ainsi que des méthodes thérapeutiques faisant appel à des compositions selon l'invention.
PCT/US1999/017886 1998-08-07 1999-08-06 Nouvelles molecules de la famille de proteines apparentees a tango-93 et leurs utilisations Ceased WO2000008045A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU57722/99A AU5772299A (en) 1998-08-07 1999-08-06 Novel molecules of the tango-93-related protein family and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13126398A 1998-08-07 1998-08-07
US09/131,263 1998-08-07

Publications (2)

Publication Number Publication Date
WO2000008045A2 WO2000008045A2 (fr) 2000-02-17
WO2000008045A3 true WO2000008045A3 (fr) 2000-06-02

Family

ID=22448668

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/017886 Ceased WO2000008045A2 (fr) 1998-08-07 1999-08-06 Nouvelles molecules de la famille de proteines apparentees a tango-93 et leurs utilisations

Country Status (2)

Country Link
AU (1) AU5772299A (fr)
WO (1) WO2000008045A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035268A1 (fr) 1998-01-09 1999-07-15 Immunex Corporation Adn codant il-1 delta et polypeptides il-1 delta
US6541623B1 (en) * 1998-04-03 2003-04-01 Hyseq, Inc. Interleukin—1 receptor antagonist and uses thereof
EP2319929A1 (fr) 1998-12-23 2011-05-11 Genentech, Inc. Polypeptides de type IL-1
EP1200593A2 (fr) * 1999-07-16 2002-05-02 Interleukin Genetics, Inc. Gene il-1l1 et produits polypeptidiques
WO2003010291A2 (fr) * 2001-07-25 2003-02-06 Hyseq, Inc. Traitement de troubles concernant les cellules immunitaires et les cellules b
CA2499843A1 (fr) * 2002-09-25 2004-04-08 Genentech, Inc. Nouvelles compositions et methodes de traitement du psoriasis
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
WO2005079566A2 (fr) * 2004-02-12 2005-09-01 Lexicon Genetics Incorporated Nouvelles disruptions geniques, compositions et procedes associes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455330A (en) * 1990-05-01 1995-10-03 Cetus Oncology Corporation Interleukin-1 antagonist and uses thereof
WO1998047921A1 (fr) * 1997-04-21 1998-10-29 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455330A (en) * 1990-05-01 1995-10-03 Cetus Oncology Corporation Interleukin-1 antagonist and uses thereof
WO1998047921A1 (fr) * 1997-04-21 1998-10-29 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EST-STS ON MASPAR SEARCH WASHU-HHMI EST PROJECT (ST. LOUIS, MO, USA); MARRA ET AL.: "mb49b11.rl Soares mouse p3NMF19.5 Mus musculus cDNA clone antagonist-mouse, mRNA sequence" *
DATABASE EST-STS ON MASPAR SEARCH WASHU-HHMI EST PROJECT (ST. LOUIS, MO, USA); MARRA ET AL.: "mc16c06.rl Soares mouse p3NMF19.5 Mus Musculus cDNA clone IMAGE:348682', mRNA sequence" *

Also Published As

Publication number Publication date
WO2000008045A2 (fr) 2000-02-17
AU5772299A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
WO1999066025A3 (fr) NOUVELLES MOLECULES PROTEIQUES ET NUCLEOTIDIQUES MTbx ET LEURS APPLICATIONS
WO2002008279A3 (fr) Molecules b7-h2, nouveaux membres de la famille b7 et leurs utilisations
WO2002070652A3 (fr) Nouvelles molecules de la famille de proteines de type card et utilisations de celles-ci
EP1009752A4 (fr) Nouvelles molecules de la famille des proteines de type tango-77 et utilisations de ces molecules
WO2000052047A3 (fr) Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations
WO2002044354A3 (fr) Nouvelles molecules de la famille de proteines relatives a card et leurs utilisations
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2001000826A3 (fr) Nouvelles molecules de la famille de proteines liee a la card et utilisations de ces dernieres
WO2000019988A8 (fr) NOUVELLES MOLECULES SPECIFIQUES DE Th2 ET LEURS UTILISATIONS
WO2000046236A3 (fr) Nouvelles molecules contenant des regulateurs de signalisation de proteine g (rgs) et leurs utilisations
WO2001009328A8 (fr) Nouvelle molecule 15571 de type gpcr de la famille secretine et utilisations de cette derniere
WO2001061005A3 (fr) Nouvelles molecules de la famille de proteines du domaine pyrine, et leurs utilisations
WO2000012544A3 (fr) Nouvelles molecules d'acides nucleiques et de polypeptides irap-bp et leurs utilisations
WO2000008045A3 (fr) Nouvelles molecules de la famille de proteines apparentees a tango-93 et leurs utilisations
WO1999054437A3 (fr) Nouvelles molecules de la famille des proteines liees a t125 et utilisations de celles-ci
WO2001018216A3 (fr) Nouvelle protease calpaine 26176 et utilisations
WO2002061049A3 (fr) Nouvelles molecules de la famille des proteines pyrin/nbs/lrr et leurs utilisations
WO2001030971A3 (fr) Nouvelles molecules de la famille des proteines se rapportant aux card et leurs utilisations
WO2001077151A3 (fr) Nouvelles molecules de proteines et d'acide nucleique fdrg et utilisation desdites molecules
WO2003029434A3 (fr) Nouvelles molecules de la famille de proteines associee a la hkid-1 et utilisations desdites molecules
WO2002085939A8 (fr) Nouvelles molecules de la famille des proteines relatives au domaine card et leurs utilisations
WO2002038767A3 (fr) Nouvelles proteine recepteur couplee a une proteine g et molecules d'acides nucleiques, et utilisations associees
WO2001059065A3 (fr) Nouvelles molecules de la famille des proteines apparentees a card et leurs utilisations
WO1999062943A3 (fr) Nouvelles molecules de la famille des proteines apparentees aip et leurs utilisations
WO2000018890A3 (fr) Nouvelles molecules de proteine phosphatase et utilisation de ces molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase